Osaic Holdings’s Defiance Nasdaq Junior Biotechnology ETF IBBJ Stock Holding History

Osaic Holdings’s Portfolio IBBJ Stock Details IBBJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-202	Closed	-$6K	–	7807
2021 Q3	$6K	Buy	202 +2	+1%	+$61	﹤0.01%	6500
2021 Q2	$7K	Sell	200 -107	-35%	-$3.38K	﹤0.01%	6278
2021 Q1	$11K	Sell	307 -393	-56%	-$14.3K	﹤0.01%	5846
2020 Q4	$24K	Buy	+700	New	+$21.5K	﹤0.01%	5052

Osaic Holdings's IBBJ Position: Q4 2021 in Review

Osaic Holdings sold out of Defiance Nasdaq Junior Biotechnology ETF (IBBJ) in Q4 2021, closing a stake of 202 shares — an estimated $6K sold.

Osaic Holdings first reported a position in IBBJ in Q4 2020 and held it in 4 quarters. The position peaked at $24K in Q4 2020. 0 funds tracked by Wall St. Rank hold IBBJ as of Q4 2021.

Osaic Holdings reported no remaining Defiance Nasdaq Junior Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
Osaic Holdings sold 202 Defiance Nasdaq Junior Biotechnology ETF shares in Q4 2021, an estimated $6K.
Osaic Holdings first reported a position in Defiance Nasdaq Junior Biotechnology ETF in Q4 2020 and held it in 4 quarters.
Osaic Holdings's Defiance Nasdaq Junior Biotechnology ETF position peaked at $24K in Q4 2020.
0 funds tracked by Wall St. Rank held Defiance Nasdaq Junior Biotechnology ETF as of Q4 2021.

Based on Osaic Holdings's 13F filing for Q4 2021, filed 3 Feb 2022.